Market leading insight for tax experts
View online issue

Vaccine Research: trading divided

The First-tier Tribunal in Vaccine Research Limited Partnership v HMRC [2013] UKFTT 333 (TC) (TC00274) found that a partnership only qualified for research and development allowances on the part of its expenditure ultimately applied by a sub-contractor on that specific activity. In this respect the decision is a common sense one that echoes other recent decisions analysing the true purpose of a taxpayer’s expenditure. The curious part of the decision is that the tribunal saw a need to dissect the partnership’s single activity into trading and non-trading elements – thereby complicating an already difficult trading analysis.

The facts
The case concerned a Jersey limited partnership which purported to trade in the UK. Individual investors contributed £107m to the partnership capital £86m of...

If you or your firm subscribes to Taxjournal.com, please click the login box below:

If you do not subscribe but are a registered user, please enter your details in the following boxes:

Alternatively, you can register free of charge to read a limited amount of subscriber content per month.
Once you have registered, you will receive an email directing you back to read this article in full.
Please reach out to customer services at +44 (0) 330 161 1234 or 'customer.services@lexisnexis.co.uk' for further assistance.
EDITOR'S PICKstar
Top